| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |